Jane Arboleda

1.1k total citations
7 papers, 859 citations indexed

About

Jane Arboleda is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Jane Arboleda has authored 7 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Jane Arboleda's work include HER2/EGFR in Cancer Research (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Estrogen and related hormone effects (1 paper). Jane Arboleda is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Estrogen and related hormone effects (1 paper). Jane Arboleda collaborates with scholars based in United States, Ireland and India. Jane Arboleda's co-authors include Slamon Dj, Liliana Ramos, Richard J. Pietras, Pegram, Dennis J. Slamon, John Crown, Yuhua Wang, Lucy Chow, Brigid C. Browne and Neil A. O’Brien and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Jane Arboleda

7 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Arboleda United States 5 575 414 251 239 157 7 859
John Cairns United Kingdom 7 835 1.5× 455 1.1× 407 1.6× 188 0.8× 268 1.7× 13 1.1k
Malgorzata Beryt United States 9 970 1.7× 393 0.9× 437 1.7× 141 0.6× 345 2.2× 10 1.3k
Brigid C. Browne Ireland 14 570 1.0× 548 1.3× 198 0.8× 43 0.2× 129 0.8× 22 969
Andrea Rosner United States 12 341 0.6× 569 1.4× 122 0.5× 96 0.4× 310 2.0× 16 929
Farahnaz Forozan United States 7 340 0.6× 662 1.6× 60 0.2× 320 1.3× 275 1.8× 8 1.0k
Rena D. Callahan United States 6 389 0.7× 333 0.8× 125 0.5× 110 0.5× 143 0.9× 12 629
Charlene Kay United Kingdom 16 443 0.8× 433 1.0× 140 0.6× 158 0.7× 366 2.3× 31 954
Thomas Waerner Germany 10 306 0.5× 636 1.5× 130 0.5× 83 0.3× 150 1.0× 13 866
Marianela Pérez-Torres United States 8 816 1.4× 483 1.2× 413 1.6× 42 0.2× 132 0.8× 13 1.1k
Stephan Duss Switzerland 12 682 1.2× 669 1.6× 53 0.2× 226 0.9× 520 3.3× 13 1.3k

Countries citing papers authored by Jane Arboleda

Since Specialization
Citations

This map shows the geographic impact of Jane Arboleda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Arboleda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Arboleda more than expected).

Fields of papers citing papers by Jane Arboleda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Arboleda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Arboleda. The network helps show where Jane Arboleda may publish in the future.

Co-authorship network of co-authors of Jane Arboleda

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Arboleda. A scholar is included among the top collaborators of Jane Arboleda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Arboleda. Jane Arboleda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Arboleda, Jane, et al.. (2017). The Next Journey: Moving Forward After Cancer Diagnosis and Treatment
.. PubMed. 21(4). 411–412. 1 indexed citations
2.
O’Brien, Neil A., Brigid C. Browne, Lucy Chow, et al.. (2010). Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib. Molecular Cancer Therapeutics. 9(6). 1489–1502. 249 indexed citations
3.
Chow, Lucy, Charles Ginther, Jane Arboleda, et al.. (2009). The role of receptor tyrosine kinase and activated PI3K signaling in response/resistance to HER-2 targeted therapy.. Cancer Research. 69(2_Supplement). 2013–2013. 1 indexed citations
4.
Mirhashemi, Ramin, J. Fernando Arena, Tony Frudakis, et al.. (2002). Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel. The Scientific World JOURNAL. 2. 19–20. 4 indexed citations
5.
Konecny, Gottfried E., Jane Arboleda, Carol Wilson, et al.. (2001). Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.. PubMed. 7(8). 2448–57. 58 indexed citations
6.
Pietras, Richard J., et al.. (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.. PubMed. 10(12). 2435–46. 493 indexed citations
7.
Kimura, Eizo, et al.. (1993). Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60.. Journal of Clinical Oncology. 11(5). 891–898. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026